GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shenzhen Kangtai Biological Products Co Ltd (SZSE:300601) » Definitions » EV-to-Revenue

Shenzhen Kangtai Biological Products Co (SZSE:300601) EV-to-Revenue : 6.83 (As of Jun. 06, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Shenzhen Kangtai Biological Products Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Shenzhen Kangtai Biological Products Co's enterprise value is ¥21,740 Mil. Shenzhen Kangtai Biological Products Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ¥3,181 Mil. Therefore, Shenzhen Kangtai Biological Products Co's EV-to-Revenue for today is 6.83.

The historical rank and industry rank for Shenzhen Kangtai Biological Products Co's EV-to-Revenue or its related term are showing as below:

SZSE:300601' s EV-to-Revenue Range Over the Past 10 Years
Min: 4.7   Med: 16.29   Max: 78.85
Current: 6.83

During the past 12 years, the highest EV-to-Revenue of Shenzhen Kangtai Biological Products Co was 78.85. The lowest was 4.70. And the median was 16.29.

SZSE:300601's EV-to-Revenue is ranked worse than
82.99% of 1023 companies
in the Drug Manufacturers industry
Industry Median: 2.26 vs SZSE:300601: 6.83

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-06), Shenzhen Kangtai Biological Products Co's stock price is ¥17.45. Shenzhen Kangtai Biological Products Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥2.88. Therefore, Shenzhen Kangtai Biological Products Co's PS Ratio for today is 6.07.


Shenzhen Kangtai Biological Products Co EV-to-Revenue Historical Data

The historical data trend for Shenzhen Kangtai Biological Products Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shenzhen Kangtai Biological Products Co EV-to-Revenue Chart

Shenzhen Kangtai Biological Products Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 29.02 51.55 18.32 11.45 9.06

Shenzhen Kangtai Biological Products Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.10 9.79 11.14 9.06 8.20

Competitive Comparison of Shenzhen Kangtai Biological Products Co's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Shenzhen Kangtai Biological Products Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shenzhen Kangtai Biological Products Co's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shenzhen Kangtai Biological Products Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Shenzhen Kangtai Biological Products Co's EV-to-Revenue falls into.



Shenzhen Kangtai Biological Products Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Shenzhen Kangtai Biological Products Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=21740.018/3180.715
=6.83

Shenzhen Kangtai Biological Products Co's current Enterprise Value is ¥21,740 Mil.
Shenzhen Kangtai Biological Products Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥3,181 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shenzhen Kangtai Biological Products Co  (SZSE:300601) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Shenzhen Kangtai Biological Products Co's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=17.45/2.876
=6.07

Shenzhen Kangtai Biological Products Co's share price for today is ¥17.45.
Shenzhen Kangtai Biological Products Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥2.88.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shenzhen Kangtai Biological Products Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Shenzhen Kangtai Biological Products Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Shenzhen Kangtai Biological Products Co (SZSE:300601) Business Description

Traded in Other Exchanges
N/A
Address
No. 6 Kefa Road, Science and Technology Industrial Park, Nanshan District, Shenzhen, CHN, 518057
Shenzhen Kangtai Biological Products Co Ltd is a human vaccine research and development company. The company is engaged in the research and development, production and sales of recombinant hepatitis B vaccine, b -type influenza Haemophilus conjugate vaccine, measles-rubella combined live attenuated vaccine, cell-free baibai broke b Haemophilus influenzae vaccine and other products.
Executives
Liu Jian Kai Directors, executives
Tao Jin Secretary Dong
Zheng Hai Fa Directors, executives
Zhou Hui Executives
Miao Xiang Directors, executives
Wen Fei Dong Director
Du Wei Min Directors, executives
Lv Zhi Yun Supervisors
Gan Jian Hui Executives
Zhu Zheng Yu Executives
Liu Qun Executives
Li Tong Executives
Yuan Li Ping Director
Li Xiang Ming Independent director

Shenzhen Kangtai Biological Products Co (SZSE:300601) Headlines

No Headlines